Series A - GlycoEra

Series A - GlycoEra

Investment Firm

Overview

GlycoEra is a CustomGlycanengineering platform that unlocks the glycan-mediated biology to develop a pipeline of novel therapeutics.

Announced Date

Nov 05, 2021

Funding Type

Series A

Highlights

Location

Switzerland, Europe

Social

Investor Lead

Roche Venture Fund

Roche Venture Fund

Roche Venture Fund is a early_stage_venture and late_stage_venture firm.

Sofinnova Partners

Sofinnova Partners

Sofinnova Partners is a early_stage_venture and late_stage_venture and seed firm.

5AM Ventures

5AM Ventures

5AM Ventures is a early_stage_venture and late_stage_venture and post_ipo and private_equity and seed and venture firm.

Participant Investors

4

Investor Name
Participant InvestorLimmaTech Biologics
Participant Investor5AM Ventures
Participant InvestorSofinnova Partners
Participant InvestorRoche Venture Fund

Round Details and Background

GlycoEra raised $49334802 on 2021-11-05 in Series A

GlycoEra is a CustomGlycanengineering platform that unlocks the glycan-mediated biology to develop a pipeline of novel therapeutics.

Company Funding History

2

Announcment DateTransaction NameNumber Of InvestorsLead InvestorMoney Raised
Nov 05, 2021
Series A - GlycoEra
4-49.3M
Jan 05, 2024
Series A - GlycoEra
4-undefined

Recent Activity

There is no recent news or activity for this profile.